about
Exposure of mice to topical bovine thrombin induces systemic autoimmunityHypercoagulation and thrombophilia in liver disease.Platelets from thrombocytopenic ponies acutely infected with equine infectious anemia virus are activated in vivo and hypofunctional.High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system.New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa.Platelet functions beyond hemostasis.Platelet activation in patients with thrombotic thrombocytopenic purpura.Reticulated platelet counts in patients undergoing autologous bone marrow transplantation: an aid in assessing marrow recovery.The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia.Low intensity laser therapy speeds wound healing in hemophilia by enhancing platelet procoagulant activity.The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.Coagulation 2006: a modern view of hemostasis.Platelets and thrombin generation.Safety profile of recombinant factor VIIa.Protease-activated receptor-2 signaling triggers dendritic cell development.Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease.Some things I thought I knew about tissue factor that turn out to be wrong.Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin.Dysregulation of hemostasis by cancer.Wound healing in hemophilia B mice and low tissue factor mice.Wound healing in haemophilia--breaking the vicious cycle.Heparin cofactor II and thrombin Heparin-binding proteins linking hemostasis and inflammation.Hypothesis: hyperhomocysteinemia is an indicator of oxidant stress.The multiple roles of tissue factor in wound healing.Hemostatic properties of the FVIIa analog NN1731.Mechanisms and monitoring of bypassing agent therapy.Practical coagulation for the blood banker.Superactivated platelets: thrombus regulators, thrombin generators, and potential clinical targets.Novel oral anticoagulants and reversal agents: Considerations for clinical development.Coagulation in Liver Disease.A mouse bleeding model to study oral anticoagulants.An activated factor VII variant with enhanced tissue factor-independent activity speeds wound healing in a mouse hemophilia B model.Protein C inhibitor (plasminogen activator inhibitor-3) expression in the CWR22 prostate cancer xenograft.Deencryption of cellular tissue factor is independent of its cytoplasmic domain.Alpha-macroglobulin secreted by alveolar macrophages serves as a binding protein for a macrophage-derived homologue of platelet-derived growth factor.Reversal of dabigatran effects in models of thrombin generation and hemostasis by factor VIIa and prothrombin complex concentrate.The effects of heparin cofactor II-derived chemotaxins on neutrophil actin conformation and cyclic AMP levels.Circulating and binding characteristics of wild-type factor IX and certain Gla domain mutants in vivo.Progressive improvement in wound healing with increased therapy in haemophilia B mice.Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia.
P50
Q28363428-6E610692-62AF-4A94-8038-9076FC59FE69Q30444596-AF775DD7-C499-412F-AEDF-00D91BA5708AQ33329150-A772D289-A30D-4C9E-9CD1-E2D5B0A7A9D5Q33338284-5D2399E7-3AF7-4912-9D2A-CD0366EF8D9BQ33347337-12DBAABF-EBE6-4244-82C5-515D418CF2C8Q33385887-AEF0CDBF-10CC-44AD-A9C8-987D8D1CF0DFQ33489187-53FA2533-573C-4DAA-898A-9BDCB755EE33Q33491715-86FC3BD0-9583-484D-A887-6297361484CDQ34090261-74BFFF0B-326F-47BD-B185-05400DCD32F6Q34375477-11E1EC89-3399-409D-AB79-7DDE4B750888Q34458071-229D88D0-D0BF-42A2-82D2-AAE863897FC2Q34606940-257FBE7E-C465-4BCB-80BC-3B8D1509548CQ34858543-FB313B88-064C-4EC1-AB53-A8E06A20699DQ35661521-ED4A1C81-A74B-4CB7-B92C-39C238FB5654Q35791420-EC75B7C5-042F-414A-8E89-6AB022EC4F72Q36860926-B6A8359A-132A-49F8-BFD2-65557CF52343Q37240197-9A371DBC-D9CE-438E-82FC-721D518B5A75Q37426582-C96128F8-74F5-4C9A-84C4-0F38135C4321Q37450924-0F8A6CEE-6C80-4595-A7DC-54904805E72CQ37695429-0B253A1E-9480-44CD-AD23-604FD31E9B0BQ37768479-C2AD3A8B-8879-4AF7-A306-90784B2D533CQ37829787-895C2BBF-4C4D-4D87-8AB5-B55451FC431CQ37941284-236E0054-9933-429F-BB20-F14BDFEC5936Q37971803-BE2326E5-7740-486D-8788-2B09DD6BE23AQ37996793-3CD3C9CF-65B7-4CE7-8C0D-BE8F9C15A2B0Q38013201-58A70AC6-23D7-4F18-978E-8EAB8CED91F0Q38096457-55E0432C-9EB9-48B6-A2C8-9122B0BBB9C9Q38122358-D19A97EE-FE80-4FD3-A8BF-EE207BBA7583Q38509194-9115715D-C925-45CD-B89B-D451AD216EFEQ38517928-98F00709-4D0F-4009-AFD0-04BC832E4F62Q39372785-4EACF28C-1B93-460C-8CE9-3C31EAF122ABQ39940714-E2F40482-519F-4C84-88CE-2FB04D8E9240Q40425949-FCE93EE4-265A-4710-8301-6A82170C9777Q40876692-63A7FB89-B8E9-4BF8-A300-D382754544B4Q41258565-2B479316-B4B0-4BCA-95F5-F0E30B846015Q41696875-EF35178A-F604-43DC-A152-EE9AA1208AA6Q43670278-591800F7-ABA8-4155-9286-DB9D0CA02DBDQ44031704-5845B810-3BED-4B88-A253-7C02BCF186F8Q44088511-A331B43D-B534-4057-9ABD-69C4848F808EQ44518904-64199651-90BC-4330-8EA0-D0FC1E582258
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maureane Hoffman
@ast
Maureane Hoffman
@en
Maureane Hoffman
@es
Maureane Hoffman
@nl
Maureane Hoffman
@sl
type
label
Maureane Hoffman
@ast
Maureane Hoffman
@en
Maureane Hoffman
@es
Maureane Hoffman
@nl
Maureane Hoffman
@sl
prefLabel
Maureane Hoffman
@ast
Maureane Hoffman
@en
Maureane Hoffman
@es
Maureane Hoffman
@nl
Maureane Hoffman
@sl
P106
P1153
35426881300
P21
P2798
P31
P496
0000-0001-7123-0100